East End Medical

East End Medical is a private U.S. medical device company developing and commercializing catheter-based cardiovascular tools for transseptal access. Its lead and apparently primary product is the SafeCross Transseptal Radiofrequency Puncture and Steerable Balloon Introducer System, an all-in-one device designed to help physicians obtain predictable and safe left atrial access during electrophysiology and structural heart procedures. The company received FDA clearance for SafeCross in 2021 and announced first commercial use in 2022. East End Medical positions its technology around improved procedural precision, visibility, workflow, and safety in transseptal puncture. The company appears to operate as a focused commercial-stage cardiovascular device developer rather than a therapeutics biotech company.